2 S&P 500 Dividend Stocks That Could Climb More Than 20% According to Wall Street Analysts

Group 1: Eli Lilly - Eli Lilly's stock price has fallen significantly, but analysts expect a rebound with a consensus price target of $950.17, indicating a potential increase of over 29% from a recent price of $735 per share [4] - The decline in stock price was attributed to disappointing results from a clinical trial for orforglipron, which showed a 12.4% average weight reduction after 72 weeks, compared to a 20.9% reduction with Zepbound [5] - Total sales of tirzepatide, an active ingredient in Zepbound and Mounjaro, surged by 121% year over year, reaching $14.7 billion in the first half of 2025, indicating strong growth potential [6] - Eli Lilly's dividend yield is currently low at 0.8%, but the company has more than doubled its dividend payout over the past five years, suggesting future income potential [9] Group 2: ConocoPhillips - ConocoPhillips shares are down about 30% from their all-time high, but analysts have a consensus target of $120.95, implying a potential gain of about 28% from a recent price of $95 per share [10] - The company has maintained a quarterly dividend payout of $0.78 per share, resulting in a dividend yield of 3.3%, while also prioritizing shareholder returns through share buybacks [10][11] - ConocoPhillips is expected to see annual free cash flow rise by more than $7 billion over the next four years, supported by asset sales and tax benefits [12]